Subsidy for medical expenses for treatment of the new coronavirus (when hospitalized) 新型コロナウイルス感染症の医療費の公費負担（入院したとき）について【２０２３年１０月１日から２０２４年３月３１日までの制度】 Share!FacebookEmailTwitterWhatsApp 2023/10/16 Monday Announcements, Coronavirus [System valid from October 1, 2023 until March 31, 2024] Public expense subsidy (when hospitalized for treatment for the new coronavirus) The following items (1) and (2) are covered by public funds. (1) Part of the medical costs of hospitalization due to coronavirus infection. (2) Part of drug costs when the following high-cost drugs are prescribed for treatment. Oral medicines “Lagebrio”, “Paxlovid” and “Xocova”. Intravenous medications ” Vecluri “. Neutralizing antibody medications “Zebudi”, “Lonaprieve” and “Evusheld”. Details of the subsidy to cover part of the costs of medicines In principle, public funds subsidize so that the maximum amount to be paid by the patient is the treatment costs minus 10,000 yen in the high-cost healthcare system. * Click here for the maximum payment amount after reduction by public funds. Click here for information about the subsidy when receiving outpatient treatment for coronavirus treatment. Share!FacebookEmailTwitterWhatsApp « Subsidy for medical expenses for treatment of the coronavirus (when receiving outpatient treatment) Housing consultation sessions (Information from Mie Prefectural Residential Support Committee) » ↑↑ Next Information ↑↑ Subsidy for medical expenses for treatment of the coronavirus (when receiving outpatient treatment) 2023/10/16 Monday Announcements, Coronavirus 新型コロナウイルス感染症の医療費の公費負担（外来診療を受けたとき）について 【２０２３年１０月１日から２０２４年３月３１日までの制度】 Share!FacebookEmailTwitterWhatsApp [System valid from October 1, 2023 until March 31, 2024] Public expense subsidy (when receiving outpatient coronavirus treatment) Part of the costs of the following high-cost medicines prescribed for the treatment of coronavirus infection will be covered by public funds. Oral medicines “Lagebrio”, “Paxlovid” and “Xocova”. Intravenous medications ” Vecluri “. Neutralizing antibody medications “Zebudi”, “Lonaprieve” and “Evusheld”. * Other medical fees, prescription fees, medication fees and other procedure fees are not covered by public spending. Details of the subsidy to cover part of the costs of medicines The amount that must be paid by the patient is determined according to the rate for medical expenses. The amount is 9,000 yen (30%), 6,000 yen (20%), and 3,000 yen (10%). Public funds are used so that the above values do not change. Click here for information about public financing for hospitalization for coronavirus treatment. Share!FacebookEmailTwitterWhatsApp